Sign in

You're signed outSign in or to get full access.

UN

UNITED NATURAL FOODS INC (UNFI)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 FY2025 delivered steady top-line growth and better profitability: net sales rose 4.9% to $8.16B, Adjusted EBITDA grew 13.3% to $145M, and Adjusted EPS improved to $0.22, while GAAP EPS was $(0.05) .
  • Mix and efficiency were the story: natural products grew 8.2%, wholesale unit volumes rose ~3%, gross margin rate eased 20 bps YoY to 13.1% on mix and strategic investments, but OpEx leveraged 40 bps to 12.6% of sales, lifting EBITDA and cash generation .
  • Deleveraging accelerated: free cash flow was $193M in the quarter; net debt/EBITDA fell to 3.7x, the lowest since fiscal 2020, with liquidity of ~$1.31B and net debt of ~$2.05B .
  • Guidance raised again: FY25 outlook increased for net sales ($31.3–$31.7B), Adjusted EBITDA ($550–$580M), Adjusted EPS ($0.70–$0.90), and free cash flow (> $150M), reflecting execution momentum and higher customer retention amid network optimization .
  • Potential stock catalysts: continued margin rate expansion in 2H, deleveraging progress, network optimization benefits (Fort Wayne DC closure completed), and the wholesale realignment into two product-centered divisions to sharpen commercial execution .

What Went Well and What Went Wrong

  • What Went Well

    • Natural product-led growth: Natural sales up 8.2% YoY; wholesale unit volume +~3% YoY, with positive volume trends cited as validation of UNFI’s role and customer strength .
    • Operating leverage and lean execution: OpEx improved 40 bps to 12.6% of sales; lean daily management rolled out to 9 DCs with early low single-digit productivity gains and lower shrink, supporting EBITDA growth .
    • Cash flow and balance sheet: Free cash flow of $193M (up ~$77M YoY); net leverage down to 3.7x; ~$1.31B liquidity .
  • What Went Wrong

    • Gross margin rate pressure: Consolidated gross margin declined 20 bps YoY to 13.1% on lower wholesale margin rate and mix, partially offset by supplier programs, lower shrink, and higher retail GM rate .
    • Retail softness: Retail net sales fell 3.3% YoY on 5 store closures; same-store sales were down ~40 bps though sequentially improved vs Q1 .
    • Ongoing transformation costs: Restructuring and business transformation expenses persisted (e.g., $9M restructuring, $8M transformation costs), and strategic investments in commercial initiatives pressured wholesale margin rate by ~10 bps YoY .

Financial Results

Headline comparisons (oldest → newest)

MetricQ2 FY2024Q1 FY2025Q2 FY2025
Net Sales ($USD Billions)$7.775 $7.871 $8.158
GAAP Diluted EPS ($)$(0.25) $(0.35) $(0.05)
Adjusted EPS ($)$0.07 $0.16 $0.22
Gross Profit ($USD Billions)$1.035 $1.038 $1.072
Gross Margin %13.3% 13.2% 13.1%
Operating Expenses ($USD Billions)$1.010 $1.015 $1.031
OpEx % of Sales13.0% 12.9% 12.6%
Adjusted EBITDA ($USD Millions)$128 $134 $145
Free Cash Flow ($USD Millions)$116 $(159) $193
Interest Expense, net ($USD Millions)$40 $36 $38
Net Debt / Adjusted EBITDA (x)4.3x 4.2x 3.7x

Segment revenue breakdown (updated categorizations; prior year recast)

Segment Net Sales ($USD Billions)Q2 FY2024Q2 FY2025YoY %
Natural$3.715 $4.021 8.2%
Conventional$3.783 $3.861 2.1%
Retail$0.631 $0.610 (3.3%)
Eliminations$(0.354) $(0.334) (5.6%)

KPIs and operating drivers

KPIQ1 FY2025Q2 FY2025Notes
Wholesale unit volume growth (YoY)~+2% ~+3% Outperformed key Nielsen benchmarks, aided by new customer additions
Inflation (sequential)~1.5% Largely unchanged vs Q1
Lean daily management DCs2 pilots prior 9 DCs Early low single-digit productivity gains; shrink near multi-quarter lows
Liquidity ($B)$1.17 ~$1.31 Cash $44M; ABL unused capacity ~$1.27B
Net debt ($B)$2.23 ~$2.05 Down ~$182M QoQ
Retail comps (ID sales)~flat at Cub in Q1 ~−0.4% consolidated IDs; Cub positive Sequential improvement

Notes: Management disclosed Adjusted EBITDA margin of “nearly 1.8%” in Q2, the highest since Q3 FY2023, and +13 bps YoY; wholesale margin rate down ~10 bps YoY but offset by OpEx leverage .

Guidance Changes

MetricPeriodPrevious Guidance (Dec 10, 2024)Current Guidance (Mar 11, 2025)Change
Net Sales ($B)FY2025$30.6 – $31.0 $31.3 – $31.7 Raised
Net (Loss)/Income ($M)FY2025$(31) – $(3) $(13) – $3 Raised
GAAP EPS ($)FY2025$(0.45) – $(0.05) $(0.15) – $0.05 Raised
Adjusted EPS ($)FY2025$0.40 – $0.80 $0.70 – $0.90 Raised
Adjusted EBITDA ($M)FY2025$530 – $580 $550 – $580 Raised (low end)
Capital + Cloud ($M)FY2025~ $300 ~ $300 Maintained
Free Cash Flow ($M)FY2025> $100 > $150 Raised

Management noted sales growth decelerating to ~3% in 2H as new customer wins begin to cycle, but with expected ~10 bps margin rate acceleration in 2H vs 1H’s 1.74% .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 FY2024, Q1 FY2025)Current Period (Q2 FY2025)Trend
Lean/Operational efficiencyStructural efficiency initiatives (~$150M) in FY2024; sequential EBITDA improvement; network optimization underway Lean Daily Management at 9 DCs; early low single-digit productivity gains; shrink near multi-quarter lows Improving execution, scaling lean
Network optimizationBillings/Bismarck DC closures; FY2025 Fort Wayne planned Fort Wayne DC closure completed; owned real estate sales progressing; customer-first approach to transitions Executing closures, monetizing assets
Commercial model & mixUpdated multi-year strategy; go-to-market evolution Realigned wholesale into two product-centered divisions (Conventional vs. Natural/Organic/Specialty/Fresh) to deepen product expertise; Natural +8.2% YoY Specialization to support growth
Gross margin vs OpExQ1: gross margin 13.2% (down YoY); OpEx 12.9% (better YoY) Gross margin 13.1% (−20 bps YoY) on mix/investments; OpEx 12.6% (−40 bps YoY); EBITDA margin near 1.8% Margin rate pressure offset by OpEx leverage
Deleveraging & FCFFY2024 net debt 4.0x; FY2025 outlook FCF ~>$100M Q2 FCF $193M; net leverage 3.7x; FY25 FCF >$150M Faster deleveraging, higher FCF
Macro/tariffsNo major behavior shifts; prepared to manage tariff risks via diversification and supply resiliency plays learned from COVID Monitoring, agile playbook

Management Commentary

  • Strategic direction: “We delivered another quarter of improving financial results and operational execution… and again raised our full year outlook… remain firmly on track to deliver our longer-term fiscal 2027 targets” – Sandy Douglas, CEO .
  • Product-centered realignment rationale: “Product expertise was a principal focus… we aligned the wholesale business into 2 product centered divisions… Natural vs. Conventional… supported by enterprise scale in supply chain and IT” – Sandy Douglas .
  • Lean and efficiency: “Several of the newer implementations have already seen initial low single-digit productivity gains… adjusted EBITDA… nearly 1.8%… highest since Q3 FY2023” – Matteo Tarditi, CFO .
  • Cash and deleveraging: “Free cash flow… $193 million… lower our net leverage to 3.7x… first time below 4x since fiscal 2023” – Matteo Tarditi .
  • Outlook cadence: “Expect adjusted EBITDA dollars in Q3 to decline marginally sequentially from Q2 given seasonality, while margin rate improves and YoY EBITDA grows” – Matteo Tarditi .

Q&A Highlights

  • Commercial realignment execution: Specialization deepens product expertise by division while maintaining enterprise centers of excellence; intent is better pricing/promo in Conventional and faster innovation in Natural .
  • Fort Wayne DC closure implications: Some duplicate costs in Q2, benefits to flow through rest of year; step-down in D&A expected; priority is smooth customer experience in any optimization .
  • Volume and category trends: Natural growing faster; Conventional volumes roughly flat but sequentially improving and slightly better than traditional grocery benchmarks .
  • Macro/tariffs: No notable change in consumer behavior early in Q3; agile supply playbook if tariffs evolve; potential shift in “food at home vs away” watched but too early to call .
  • Pipeline: New business pipeline “very strong” across $90B addressable market; guidance reflects high-confidence baseline .

Estimates Context

  • Wall Street consensus from S&P Global (EPS and revenue for Q2 FY2025) was unavailable at the time of this analysis due to request limits; as a result, we cannot quantify beats/misses vs consensus for this quarter [GetEstimates error]. Where estimates comparisons are not shown, it reflects unavailability from S&P Global at time of request.

Key Takeaways for Investors

  • Mix-driven growth with operational discipline: Natural’s +8.2% growth and lean-driven OpEx leverage are offsetting modest gross margin rate pressure, producing double-digit Adjusted EBITDA growth .
  • Deleveraging ahead of plan: Q2 free cash flow and asset actions reduced net leverage to 3.7x; sustained FCF and property monetization could further compress leverage through FY2025 .
  • Guidance credibility improving: Second consecutive raise across sales, Adjusted EBITDA (low end), Adjusted EPS, and FCF signals confidence in execution and customer retention despite cycling of new wins in 2H .
  • Watch the 2H cadence: Seasonal Q3 step-down in dollars but higher margin rate expected; monitor how wholesale margin rate trends vs OpEx gains as realignment and supplier programs mature .
  • Strategic specialization: The two-division wholesale structure should sharpen pricing/promo (Conventional) and innovation speed (Natural), supporting category share and mix over time .
  • Retail stabilization: Retail sales declined on closures, but comps improved sequentially with Cub positive; broader narrative remains wholesaledriven .
  • Risk checks: Tariff/macro uncertainties remain; management highlights supply chain resiliency and optionality learned from COVID disruptions .

Additional Q2 Context: Other Relevant Press Releases

  • UNFI announced a wholesale business realignment into two product-centered divisions to improve customer service and commercial effectiveness (Jan 8, 2025) .

Appendix: Cross-Quarter Context (Prior Two Quarters)

  • Q1 FY2025: Net sales $7.87B (+4.2%); GAAP EPS $(0.35); Adjusted EPS $0.16; Adjusted EBITDA $134M; gross margin 13.2%; OpEx 12.9% of sales; raised FY25 outlook .
  • Q4 FY2024: Net sales $8.16B (+10.0% including 53rd week; +2.1% comparable 13-week); GAAP EPS $(0.63); Adjusted EPS $0.01; Adjusted EBITDA $143M; introduced FY2025 outlook and multi-year plan; network optimization initiated .

Citations: Press release and 8-K: ; Q2 press: ; Q1 press: ; Q4 press: ; Q2 call: ; Realignment release: .